Advancement of New Drug/Biomarker Discovery for Treatment of Diabetes

As a prognostic biomarker for progression of diabetic nephropathy, albuminuria fails in terms of sensitivity and specificity. Better urinary or plasma biomarkers are needed that can predict which diabetic patients are at highest risk for progression. Bhensdadia et al. report proteomic investigations that identified urinary haptoglobin as a potential prognostic biomarker for progressive diabetic nephropathy. Although as a single marker urinary haptoglobin adds little to albuminuria, together the two appear to provide better diagnostic accuracy than albuminuria alone. Excess adiposity is the most important risk factor for the development of insulin resistance and type 2 diabetes (1). However, mechanisms whereby body fat induces insulin resistance in distant tissues are not well understood. Recent evidence indicates that obesity may be an inflammatory markers.
  • Prognostic biomarkers
  • Diabetic nephropathy biomarkers
  • Diabetes: Clinical trials and new biomarkers under development
  • Pharmacotherapy in treatment of diabetes
  • Molecular markers for both metabolic syndrome and hypoglycemia responses
  • Inflammatory markers: Type 2 diabetes
  • New drug treatments and devices for diabetes: current research

Related Conference of Advancement of New Drug/Biomarker Discovery for Treatment of Diabetes

March 8-9, 2018

17th Global Diabetes Conference & Nursing Care

| Paris, France
May 23-24, 2018

11th Diabetologists Conference

New York, USA
June 20-21, 2018

27th European Diabetes Congress

| Rome, Italy
July 16-17, 2018 Sydney, Australia

20th Asia Pacific Diabetes Conference

July 25-26, 2018

Global Meeting on Diabetes and Endocrinology

Kuala Lumpur, Malaysia
August 20-21, 2018

28th World Congress on Diabetes, Obesity & Heart

Tokyo, Japan
September 03-04, 2018

2nd International Conference on Thyroid and Pregnancy

Auckland, New Zealand
September 3-4, 2018

11th World Congress on Endocrinology and Metabolic Disorders

Auckland, New Zealand
September 13-15, 2018

26th International Diabetes and Healthcare Conference

| Bucharest, Romania
November 26-27, 2018

13th European Diabetes and Endocrinology Congress

Dublin, Ireland

Advancement of New Drug/Biomarker Discovery for Treatment of Diabetes Conference Speakers